HYH - Halyard Health, Inc.

. Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Thomson Reuters StreetEvents9 months ago

    Edited Transcript of HYH earnings conference call or presentation 7-Aug-18 1:00pm GMT

    Q2 2018 Avanos Medical Inc Earnings Call

  • See what the IHS Markit Score report has to say about Halyard Health Inc.
    Markit11 months ago

    See what the IHS Markit Score report has to say about Halyard Health Inc.

    Short interest is low for HYH with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 6.

  • PR Newswire11 months ago

    Halyard Health Hosts Inaugural Analyst and Investor Meeting

    ALPHARETTA, Ga., June 21, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) ("Halyard", or "the Company", or "Avanos") today hosted its inaugural analyst and investor meeting in New York, where it presented the company's new strategic framework and its plan for delivering the next chapter of growth alongside an update around the company's rebranding and renaming into "Avanos". "At Avanos, we're helping our customers address some of the most significant healthcare challenges we face today. As our global marketplace continues to evolve, our company will be well-placed to deliver superior, breakthrough solutions to improve patients' quality of life and get them back to the things that matter," said Joe Woody, chief executive officer of Avanos.

  • PR Newswire11 months ago

    Halyard Health Announces 2018 Analyst and Investor Conference and Webcast

    ALPHARETTA, Ga., June 11, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) announced today that the company will host its Analyst and Investor Conference on Thursday, June 21, 2018, at the Sofitel New York from 7:30 a.m. to approximately 12:30 p.m. ET. Institutional investors, equity research analysts and debt analysts interested in attending are encouraged to contact Halyard Investor Relations at Investor.Relations@HYH.com as soon as possible to request an invitation. Halyard Health will host a webcast of the meeting to provide access to all interested stakeholders.

  • ACCESSWIRE11 months ago

    Wired News - Halyard Health to Buy CoolSystems; Marketed as Game Ready(R)

    LONDON, UK / ACCESSWIRE / June 7, 2018 / If you want access to our free research report on Halyard Health, Inc. (NYSE: HYH), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HYH as the Company's latest news hit the wire. On June 05, 2018, the Company announced that it has inked a deal to acquire CoolSystems, Inc., marketed as Game Ready®, a market-leading provider of cold therapy and compression therapy systems for a total consideration of $65 million in cash. Active-Investors.com is currently working on the research report for CAS Medical Systems, Inc. (NASDAQ: CASM), which also belongs to the Healthcare sector as the Company Halyard Health.

  • PR Newswire11 months ago

    Halyard Health Announces Agreement to Acquire CoolSystems, Inc., Marketed as Game Ready®

    ALPHARETTA, Ga., June 5, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) announced today it has entered into a definitive agreement to acquire CoolSystems, Inc., marketed as Game Ready, a market-leading provider of cold therapy and compression therapy systems for a total consideration of $65 million in cash.

  • PR Newswirelast year

    Halyard Health Announces Corporate Rebranding, Changes Name to Avanos Medical, Inc.

    ALPHARETTA, Ga., June 1, 2018 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) a market-leading medical devices company, today announced the business' rebrand to Avanos Medical, Inc. ("Avanos"). Avanos' vision is to be the best at getting patients back to the things that matter. Avanos provides pioneering pain management and chronic care therapies and solutions, with a relentless focus on advancing change in the medical devices industry to address unmet medical needs and improve patients' quality of life.

  • 3 Reasons Why Halyard Health (HYH) is a Great Momentum Stock
    Zackslast year

    3 Reasons Why Halyard Health (HYH) is a Great Momentum Stock

    Halyard Health (HYH) stock is looking quite impressive for momentum-oriented investors as it has favorable price performance and is also seeing positive estimate revisions.

  • ACCESSWIRElast year

    Free Daily Technical Summary Reports on Endologix and Three Other Medical Supplies Stocks

    Ahead of today's trading session, WallStEquities.com scans Daxor Corp. (NYSE AMER: DXR), Endologix Inc. (NASDAQ: ELGX), Glaukos Corp. (NYSE: GKOS), and Halyard Health Inc. (NYSE: HYH). Companies in the Medical Instruments and Supplies space manufacture and sell medical devices, instrument systems, and reagents and consumables.